Lexis Nexis Medical Biotechnology: Premarket and Postmarket Regulation
Select a format
International Order Inquiry
Select subscription type
Terms & conditions
Subscribers receive the product(s) listed on the Order Form and any Updates made available during the annual subscription period. Shipping and handling fees are not included in the annual price.
Subscribers are advised of the number of Updates that were made to the particular publication the prior year. The number of Updates may vary due to developments in the law and other publishing issues, but subscribers may use this as a rough estimate of future shipments. Subscribers may call Customer Support at 800-833-9844 for additional information.
Subscribers may cancel this subscription by: calling Customer Support at 800-833-9844; emailing customer.support@lexisnexis.com; or returning the invoice marked "CANCEL".
If subscribers cancel within 30 days after the product is ordered or received and return the product at their expense, then they will receive a full credit of the price for the annual subscription.
If subscribers cancel between 31 and 60 days after the invoice date and return the product at their expense, then they will receive a 5/6th credit of the price for the annual subscription. No credit will be given for cancellations more than 60 days after the invoice date. To receive any credit, subscriber must return all product(s) shipped during the year at their expense within the applicable cancellation period listed above.
The total price includes the product(s) listed in the Order Form and any Updates for a limited period (minimum period of 30 days) after the order is placed ("Order Window"). Shipping and handling fees are not included in the grand total price.
All shipments may be returned, at subscribers' expense, for full credit of the Price within 30 days of receipt.
Shipments may not be returned, and no credits will be issued, more than 30 days after receipt.
After the Order Window, subscribers will receive notice of Updates along with the then-current grand total price and order process as Updates become available. Subscribers will only be shipped those Updates they specifically request.
Product description
View a sample of this title using the ReadNow feature
Providing a current and concise introduction to U.S. Food and Drug Administration (FDA) and related federal regulation of medical devices, drugs, and biological products derived from biotechnology, this concise new guide assists attorneys who need to understand the often complicated infrastructure that governs their clients in the biotechnology industry. Based on the understanding that nearly every legal issue related to biotech clients is ultimately informed or influenced by this governing legal framework, Medical Biotechnology: Premarket and Postmarket Regulation helps lawyers in all areas, whether prosecuting biotechnology patents, negotiating IP licenses, or handling product liability issues, to name just a few. With significant experience counseling clients on a wide range of biotechnology issues, the book's authors have either worked at the FDA or have been nationally recognized for their expertise in biotechnology law, or both. Clearly written and thorough, the book's chapters also include valuable information for practitioners, including Practice Tips, acronym lists for each chapter, and extensive footnotes. Four chapters address key issues in this regulatory framework:
Chapter One explains federal regulation of preclinical research, including requirements for compliance and the penalties for noncompliance. It considers three categories of regulatory protection: protection of animals used in research; protection of the environment and public health; and protection of individuals conducting preclinical reseach.
Chapter Two provides an overview of FDA regulation of clinical trials of new biotechnology products for human use. Briefly describing the role of clinical research and the government entities that regulate it, it also discusses the roles and responsibilities of the parties involved in the research and the clinical process itself, and well as other relevant issues.
Chapter Three outlines the standard and expedited pathways to market for biotechnology products intended for human use.Chapter Four covers the notable federal laws regulations that affect production, distribution, and marketing strategies.
eBooks, CDs, downloadable content, and software purchases are noncancelable, nonrefundable and nonreturnable. Click here for more information about LexisNexis eBooks. The eBook versions of this title may feature links to Lexis+® for further legal research options. A valid subscription to Lexis+® is required to access this content.
